Clicky

Clinuvel Pharm Ords(CLVLF)

Description: Clinuvel Pharmaceuticals Ltd is a global biopharmaceutical company focused on developing drugs for the treatment of a range of severe skin disorders. With our unique expertise in understanding the interaction of light and human skin, we have identified three groups of patients with a clinical need for photoprotection and another group with a need for repigmentation. These patient groups range in size from 10,000 to 45 million.


Keywords: Biopharmaceutical Medication Pharmacy Health Sciences Pharmacology Pharmaceutical Sciences Skin Disorder Human Skin Severe Skin Disorders Treatment Of A Range Of Severe Skin Disorders

Home Page: www.clinuvel.com

535 Bourke Street
Melbourne, VIC 3000
Australia
Phone: 61 3 9660 4900


Officers

Name Title
Dr. Philippe Jacques Wolgen M.B.A., M.D., MBA CEO, MD & Director
Mr. Darren M. Keamy CFO & Company Sec.
Dr. Dennis J. Wright Chief Scientific Officer
Mr. Lachlan Hay Director of Global Operations
Mr. Malcolm Bull Head of Investor Relations

Exchange: PINK

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 56.3929
Price-to-Book MRQ: 8.2669
Price-to-Sales TTM: 10.6458
IPO Date:
Fiscal Year End: June
Full Time Employees: 0
Back to stocks